Zentalis Pharmaceuticals, Inc. Share Price
NASDAQ: ZNTL | Micro CapZentalis Pharmaceuticals, Inc. Stock Performance
Zentalis Pharmaceuticals, Inc. Share Price Today
As of 29 October 2026, Zentalis Pharmaceuticals, Inc.'s share price is $2.06. The stock opened at $2.08, compared to its previous close of $2.05. During today's trading session, Zentalis Pharmaceuticals, Inc.'s share price traded between $2.02 and $2.10, with an average price of $2.06. Over the past 52 weeks, the stock has recorded a high of $6.94 and a low of $1.22. In terms of performance, Zentalis Pharmaceuticals, Inc.'s share price has declined by 48.69% over the last six months and is up 37.92% on a year-on-year basis.
Zentalis Pharmaceuticals, Inc. Share Price Chart
Zentalis Pharmaceuticals, Inc. Quarterly Profit & Loss
All figures in USD
Zentalis Pharmaceuticals, Inc. Annual Profit & Loss
All figures in USD
About Zentalis Pharmaceuticals, Inc.
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing azenosertib (ZN-c3), a potentially first-in-class and best-in-class WEE1 inhibitor for patients with Cyclin E1-positive platinum-resistant ovarian cancer (Cyclin E1+ PROC). The Company manages its operations as a single segment for the purposes of assessing performance and making operating decisions.
Zentalis Pharmaceuticals, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $2.74 | $2.04 | -26.13% |
Sep 2026 | $3.70 | $2.75 | -28.90% |
Aug 2026 | $4.66 | $3.88 | -18.16% |
Jul 2026 | $4.79 | $4.74 | -2.27% |
Jun 2026 | $3.99 | $4.84 | +21.12% |
May 2026 | $4.00 | $4.00 | -0.12% |
Apr 2026 | $2.43 | $4.00 | +70.43% |
Mar 2026 | $2.44 | $2.35 | -1.67% |
Feb 2026 | $2.42 | $2.39 | -2.05% |
Jan 2026 | $1.33 | $2.44 | +81.41% |
Dec 2025 | $1.39 | $1.34 | -5.94% |
Nov 2025 | $1.54 | $1.43 | -4.03% |